Mission
THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO DEVELOP AND ACCELERATE ACCESS TO BREAKTHROUGH CANCER THERAPIES, CURATING INNOVATION FROM DISCOVERY TO PATIENT ACCESS.
Public Charity
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY, of SAN FRANCISCO, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $180.1M in revenue, $53.8M in expenses, $285.2M in total assets. 35 publicly reported grants to this organization, totaling roughly $303.6M, appear in IRS filings.
EIN: 473355381
SAN FRANCISCO, CA
Fund Raising & Fund Distribution
NTEE: E12
Latest filing: 2025
Total Revenue$180.1M
Total Expenses$53.8M
Total Assets$285.2M
Grant Records35
Funding Total$303.6M
Filing Years2020–2025
Where $100 goes at Parker Institute for Cancer Immunotherapy
How Parker Institute for Cancer Immunotherapy divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$87
Programs
the work itself
$13
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $87 for programs
$87
Parker Institute for Cancer Immunotherapy (pici) encourages advances in cancer immunotherapy research, collaboration, and discovery, and the translation of these advances into cures and treatments for the benefit…
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
$40,000,000
MEDICAL / PUBLIC SERVICES
$3,000,000
HEALTH
$1,603,970
For grant recipient's exempt purposes
$845,680
$57,500
Showing up to 5 of 35 total records — full history available with membership.
Officers & Directors
DIRECTOR
Ben Horowitz
DIRECTOR
Bob Hugin
DIRECTOR
Bob Nelsen
DIRECTOR
Bob Pittman
DIRECTOR
Bruce Parker Phd
SR DIR, NETWORK CLIN. RESEARCH
Chris Cabanski Thru 1225
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $180.1M | $53.8M | $285.2M |
| 2024 | $66.9M | $54.5M | $223.9M |
| 2023 | $23.7M | $42.9M | $255.0M |
| 2022 | $32.8M | $62.2M | $307.2M |
| 2020 | $66.0M | $69.9M | $152.6M |
Between 2020 and 2025, reported annual revenue grew from $66.0M to $180.1M (+173%), with total assets most recently reported at $285.2M.
Interactive year-over-year charts and full filing details available with membership.